Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 33.85
+0.05 (0.15%)
Oct 17, 2025, 2:32 PM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 25.27 billion as of October 17, 2025. Its market cap has decreased by -21.26% in one year.
Market Cap
25.27B
Enterprise Value
30.07B
Revenue
1.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
33.85
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 25.27B, an increase of 6,958.41%. That is a compound annual growth rate of 22.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 25.27B | -20.01% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | 31.74B | 30.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 251.26B |
| PharmaEssentia | 190.83B |
| Bora Pharmaceuticals Co., LTD. | 80.18B |
| Lotus Pharmaceutical | 78.76B |
| Lumosa Therapeutics | 48.85B |
| Oneness Biotech | 30.37B |
| Polaris Group | 27.74B |
| Pegavision | 23.83B |